Selvaraj, S. Et Al. 2022. Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation , vol.146, no.11 , 808-818.

Selvaraj, S., Fu, Z., Jones, P., Kwee, L. C., Windsor, S. L., Ilkayeva, O., ... Newgard, C. B.(2022). Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation , vol.146, no.11, 808-818.

Selvaraj, Senthil Et Al. "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF," Circulation , vol.146, no.11, 808-818, 2022

Selvaraj, Senthil Et Al. "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF." Circulation , vol.146, no.11, pp.808-818, 2022

Selvaraj, S. Et Al. (2022) . "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF." Circulation , vol.146, no.11, pp.808-818.

@article{article, author={Senthil Selvaraj Et Al. }, title={Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF}, journal={Circulation}, year=2022, pages={808-818} }